Drug
RNA, Small Interfering clinical trials
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2020
Keep track of what changes. Save the RNA, Small Interfering studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
ADARx Pharmaceuticals, Inc. (1) · Hoffmann-La Roche (1) · Ong Kim Yao (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses RNA, Small Interfering is read from its arms, and is right about nine times in ten.
Testing it · 3
- siRNA Microneedle Patches for Ear Keloid Post-Surgical ScarsNot yet recruitingPhase 2Ong Kim YaoNCT07596628Written as Small interfering RNA (siRNA) Microneedle Patches
- Safety, Tolerability, PK and PD of ADX-850 in Participants With HypertensionActive, not recruitingPhase 1ADARx Pharmaceuticals, Inc.NCT06205628Written as ADX-850
- A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis BCompletedPhase 2Hoffmann-La RocheNCT04225715Written as siRNA (RO7445482)
Codes
What other systems call RNA, Small Interfering · ClinicalTrials.gg INT008818
- MeSH (NLM) D034741RNA, Small InterferingOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D034741 | RNA, Small Interfering | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.